Insurance hot topics virtual series: Transform your insurance data with a digital strategy

Free Live CPE Webinars

Participants of the live webinar will be eligible for 1 free CPE credit. Register Join us for the fourth webinar in this year's insurance hot topics virtual series: Data analytics challenges for insurers. As our digital world evolves, insurance companies are finding more ways to tap into new and existing data sources to better understand […]

Free

SOC: lessons learned from a year of remote engagements

Free Live CPE Webinars

Participants of the live webinar will be eligible for 1 free CPE credit. Register System and Organization Controls (SOC) examinations, in many cases, transformed overnight into a completely virtual experience because of the pandemic. Join Baker Tilly as we analyze the internal control environment and areas that have been most affected by this change. We […]

Free

2021 Insurance regulatory insights: A regulator panel discussion

Free Live CPE Webinars

Participants of the live webinar will be eligible for 1 free CPE credit. Register Over the course of our 2020-2021 insurance hot topics virtual series, we covered pertinent accounting, financial, operational and transformational updates, and provided guidance for insurance companies moving forward. In the fifth webinar in this year’s series, Baker Tilly Financial Services Partner […]

Free

The evolution of the medical affairs profession

Free Live CPE Webinars

Participants of the live webinar will be eligible for 1 free CPE credit. Register Medical affairs is a critical functional area for the life sciences industry whose role and responsibilities within the organization have been experiencing tremendous growth. Most recently, there have been increased demands for scientific evidence from the medical community due to the […]

Free

Preparing for the successful launch and commercialization of a pharmaceutical product

Free Live CPE Webinars

Participants of the live webinar will be eligible for 1 free CPE credit. Register Bringing a novel pharmaceutical or life sciences product to market has always been an arduous undertaking, even before the onset of the coronavirus pandemic. In fact, a study by McKinsey reported that 40% of worldwide drug launches between 2009 and 2017 failed to […]

Free
Subscribe Here